Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Life Sciences : CMLS|May 28, 2020
Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathwaysAlexander J Cole, Kristie-Ann Dickson, Christopher Liddle, et al.
Journal of Pharmaceutical Sciences|October 26, 2016
Host-Guest Complexes of Carboxylated Pillar[n]arenes With DrugsNial J Wheate, Kristie-Ann Dickson, Ryung Rae Kim, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 28, 2025
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screensTali S Skipper, Kristie-Ann Dickson, Christopher E Denes, et al.
Human Molecular Genetics|June 27, 2023
CRISPR single base-editing: in silico predictions to variant clonal cell linesKristie-Ann Dickson, Natisha Field, Tiane Blackman, et al.
Scientific Reports|May 19, 2016
Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencingAlexander J Cole, Trisha Dwight, Anthony J Gill, et al.
Scientific Data|September 6, 2017
Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequencyAlexander J Cole, Ying Zhu, Trisha Dwight, et al.
Molecular Therapy. Oncology|January 13, 2025
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancerBayley Matthews, Michelle Wong-Brown, Dongli Liu, et al.
Cancers|September 14, 2024
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant SubtypesYue Ma, Natisha R Field, Tao Xie, et al.
Cancer Medicine|April 9, 2026
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma ViabilityYue Ma, Kristie-Ann Dickson, Farhana A Sarker, et al.
Human Molecular Genetics|November 1, 2016
The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerKristie-Ann Dickson, Alexander J Cole, Anthony J Gill, et al.
Pageof 3